Round Rock Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Round Rock Advisors’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$204K	Hold	3,538	–	–	0.03%	316
2026 Q1	$215K	Buy	+3,538	New	+$206K	0.03%	306
2025 Q2	–	Sell	-3,618	Closed	-$221K	–	220
2025 Q1	$221K	Buy	3,618 +57	+2%	+$3.32K	0.04%	196
2024 Q4	$201K	Buy	+3,561	New	+$199K	0.04%	207
2023 Q1	–	Sell	-5,713	Closed	-$411K	–	146
2022 Q4	$411K	Buy	5,713 +969	+20%	+$73.1K	0.17%	94
2022 Q3	$333K	Hold	4,744	–	–	0.15%	98
2022 Q2	$365K	Buy	+4,744	New	+$361K	0.16%	92

Other funds holding BMY

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Round Rock Advisors's BMY Position: Q2 2026 in Review

Round Rock Advisors held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,538 shares worth $204K. The position accounts for 0.03% of the portfolio, ranked #316.

Round Rock Advisors first reported a position in BMY in Q2 2022 and has held it in 7 quarters since. The position peaked at $411K in Q4 2022. 2,517 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Round Rock Advisors held 3,538 shares of Bristol-Myers Squibb worth $204K as of Q2 2026.
Round Rock Advisors left its Bristol-Myers Squibb share count unchanged in Q2 2026.
Bristol-Myers Squibb made up 0.03% of Round Rock Advisors's portfolio in Q2 2026, its #316 holding.
Round Rock Advisors first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 7 quarters since.
Round Rock Advisors's Bristol-Myers Squibb position peaked at $411K in Q4 2022.
2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Round Rock Advisors's 13F filing for Q2 2026, filed 12 Aug 2026.